Chemopreventive promise of targeting the Nrf2 pathway

被引:48
|
作者
Yates, Melinda S.
Kensler, Thomas W.
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1358/dnp.2007.20.2.1083437
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Kelch ECH associating protein 1-nuclear factor-E2-related factor 2-antioxidant response element (Keap 1-Nrf2-ARE) signaling pathway regulates several protective mechanisms including expression of conjugating and antioxidative genes, antiinflammatory responses, the molecular chaperone/stress response system and the ubiquitin/proteasome system. The Nrf2-mediated response alters susceptibility to carcinogenesis, acute chemical toxicity, oxidative stress, asthma, acute inflammation, septic shock and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Studies using natural and synthetic chemical inducers that activate Nrf2 signaling have demonstrated protective efficacy in many animal models of disease. Conversely, studies in Nrf2-disrupted mice indicate they exhibit increased sensitivity to many of these diseases. Thus, activation of Keap1-Nrf2-ARE signaling constitutes a broad protective response, making Nrf2 and its interacting partners important targets for chemoprevention. However, additional studies are needed to characterize Keap1-Nrf2-ARE signaling in humans to further develop exceptionally potent activators of the pathway and further understand the potential consequences of altering this system. (c) 2007 Prous Science. All rights reserved.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 50 条
  • [31] Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
    Li, Botong
    Wang, Yixuan
    Jiang, Xiaolin
    Du, Hongwei
    Shi, Yan
    Xiu, Minghui
    Liu, Yongqi
    He, Jianzheng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [32] Targeting Nrf2 signaling in dry eye
    Zhang, Yu-Nuo
    Ouyang, Wei-Jie
    Hu, Jiao-Yue
    Liu, Zu-Guo
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (10) : 1911 - 1920
  • [33] Targeting NRF2 to promote epithelial repair
    Hiebert, Paul
    Werner, Sabine
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (01) : 101 - 111
  • [34] Flavonoids targeting NRF2 in neurodegenerative disorders
    Khan, Haroon
    Tundis, Rosa
    Ullah, Hammad
    Aschner, Michael
    Belwal, Tarun
    Mirzaei, Hamed
    Akkol, Esra Kupeli
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 146
  • [35] Targeting Nrf2 to treat thyroid cancer
    Gong, Zhongqin
    Xue, Lingbin
    Li, Huangcan
    Fan, Simiao
    van Hasselt, Charles Andrew
    Li, Dongcai
    Zeng, Xianhai
    Tong, Michael Chi Fai
    Chen, George Gong
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [36] Targeting NRF2 signaling for cancer chemoprevention
    Kwak, Mi-Kyoung
    Kensler, Thomas W.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 244 (01) : 66 - 76
  • [37] Advances and challenges in therapeutic targeting of NRF2
    Dinkova-Kostova, Albena T.
    Copple, Ian M.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (03) : 137 - 149
  • [38] Flazin as a Promising Nrf2 Pathway Activator
    Fuda, Hirotoshi
    Miyanaga, Satoshi
    Furukawa, Takayuki
    Umetsu, Satomi
    Joko, Sae
    Roan, Yuning
    Suzuki, Hirotaka
    Hui, Shu-Ping
    Watanabe, Mitsugu
    Chiba, Hitoshi
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2019, 67 (46) : 12844 - 12853
  • [39] Physiology, pharmacology and toxicology of the Nrf2 pathway
    Copple, I.
    TOXICOLOGY LETTERS, 2018, 295 : S34 - S34
  • [40] Advance in Nrf2 Signaling Pathway in Leishmaniasis
    Saha, Sarmistha
    Sachivkina, Nadezhda
    Kuznetsova, Olga
    Neborak, Ekaterina
    Zhabo, Natallia
    BIOMEDICINES, 2024, 12 (11)